LINDSEY KENT: Open Payments
NPI 1740986322 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 21 payments from 7 companies in 2025. Trend: 2023 $1,266 · 2024 $1,087 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $169 |
| Medtronic, Inc. | 1 | $122 |
| Tandem Diabetes Care, Inc. | 1 | $84 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Sequel Med Tech, LLC | 1 | $29 |
| Dexcom, Inc. | 1 | $16 |
Products named: Ozempic, JARDIANCE, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, TWIIST, Wegovy, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
